- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
DermTech (NASDAQ:DMTK), Quotes and News Summary
DermTech (NASDAQ: DMTK)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-08 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.010 | -0.990 | 0.0200 | ||||
| REV | 4.810M | 4.233M | -577.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
DermTech Questions & Answers
You can purchase shares of DermTech (NASDAQ: DMTK) through any online brokerage.
Other companies in DermTech’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Immuneering (NASDAQ:IMRX), Viracta Therapeutics (NASDAQ:VIRX), La Jolla Pharmaceutical (NASDAQ:LJPC) and Talaris Therapeutics (NASDAQ:TALS).
The latest price target for DermTech (NASDAQ: DMTK) was reported by Oppenheimer on Wednesday, August 17, 2022. The analyst firm set a price target for 23.00 expecting DMTK to rise to within 12 months (a possible 302.80% upside). 4 analyst firms have reported ratings in the last year.
The stock price for DermTech (NASDAQ: DMTK) is $5.71 last updated August 19, 2022, 8:00 PM UTC.
There are no upcoming dividends for DermTech.
DermTech’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for DermTech.
DermTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.